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RESOLUTION OF SYMPTOMATIC IMMOBILIZATION HYPERCALCEMIA (IH)
AFTER REHABILITATION EXERCISES IN A HEMODIALYSIS PATIENT
Sun Ae Yoon, Young Ok Kim, Yu Seon Yun
Department of Internal Medicine, Uijongbu St. Mary’s Hospital, The Catholic
University of Korea, School of Medicine, Seoul, Korea
The patient is a 76-year-old Korean female who had been thrice-weekly
hemodialysis for 3 months for ESRD attributable to diabetic nephropathy. She
presented to emergency room with decreased mentality. Before admission, she
had been bed-ridden status for 4 months due to poor general condition. Brain
CT and MRI showed negative ﬁndings. Serum calcium was 15.6 mg/dl, ionized
calcium 2.12 mmol/L, hypercalciuria (FECa 26.2%), and low serum levels of iPTH
(42.92 pg/ml) suggested non-parathyroidal hypercalcemia. Two weeks ago, her
serum calcium and phosphate level was 9.0 and 6.1 mg/dl, respectively and she
was receiving calcium acetate. An extensive workup failed to identify any
etiology of hypercalcemia. Hypercalcemia was temporarily ameliorated after
withdrawal calcium-containing phosphate binder and daily hemodialysis with
low calcium (Caþþ 1.25 mmol/L) dialysate but recurred one week later. Serum
calcium level was increased and reached to 12.2–13.5 mg/dl. Immobilization
hypercalcemia was considered after the exclusion of other discernible causes.
We decided to try rehabilitation exercises. Two weeks after passive range of
motion (ROM) exercise of joints and tilting table standing, serum calcium level
was decreased to below 10.5 mg/dl.
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IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS
Valerie Young, Linda Orazio, Sunil V Badve, Annerley Bates, David
W Johnson, Katrina L Campbell
Princess Alexandra Hospital, Brisbane, Queensland, Australia
The purpose of this study is to identify barriers related to achieving an
adequate protein intake, and predictors of protein-energy wasting (PEW) in
Peritoneal Dialysis (PD) patients.
This is a prospective observational study of prevalent patients receiving
PD in our facility. Data collection occurs at baseline and six months,
including renal-related morbidity, biochemistry, weight, nutritional status
(Subjective Global Assessment (SGA) and PEW criteria), energy and protein
intake (via diet history), social situation and support, appetite and quality
of life (EQ-5D). The following is a preliminary analysis of baseline
characteristics, using chi-square, Fisher’s exact test and t-test, against
protein intake less than or greater than the recommended 1.2 g/kg
adjusted body weight (ABW).
To date, 43 patients have been recruited, 56% (n¼24) are male, with
mean (SD) age 61 (12.3) years and BMI 28.5 (7.3) kg/m2. Of these, 16%
(n¼7) were assessed as malnourished (SGA B or C) and 93% (n¼40) met
one or more PEW criteria. Sixty percent (n¼26) failed to meet minimum
protein requirements 1.2 g protein/kg ABW (mean 1.08 (0.3) g protein/kg
ABW). Inadequate protein intake was related to reliance on social security
(p¼0.05), having a diminished appetite (p¼0.05) and lower reported
quality of life (health utility index) (p¼0.03). PEWwas related to decreased
mobility (p¼0.05), difﬁculties with self care (p¼0.001) and presence of
pain/discomfort (p¼0.01).
In conclusion, inadequate protein intake was present in a signiﬁcant
portion of the population. Barriers to adequate intake in this population
can include low income and appetite levels, which may concomitantly
impact on quality of life. Further work on recruiting participants and
longitudinal follow-up is currently underway to elucidate the impact of
this on patient outcomes.
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EFFECT OF HIGH SALT ON RENAL NKCC2 IN CYP4F2 TRANSGENIC MICE
Yanyan Zhao, Jingjing Wu, Guangrei Lai
Department of Clinical Genetics, Shengjing Hospital of China Medical
University, Shenyang, Liaoning, ChinaCytochrome P450 4F2 (CYP4F2) catalyzes theo-hydroxylation of arachidonic
acid (AA) to 20-HETE.We previously generated a CYP4F2 transgenic (TG) mouse
model, and demonstrated that overexpressed CYP4F2 elevates 20-HETE
production and blood pressure in the TG mice, indicating 20-HETE plays a
prohypertensive role via vasoconstriction in CYP4F2 TG mice. To investigate
antihypertensive action of 20-HETE via natriuresis in CYP4F2 TG mice , we fed
TG mice a high salt (4% NaCl) diet for 2 weeks, and measured their systolic
blood pressure (SBP), urine sodium concentration, urine volume, and urinary
20-HETE excretion. The expression of renal Naþ-Kþ-2Cl- cotransporter, isoform
2 (NKCC2) was detected by Real-time PCR and Western blot. The results
showed that SBP was not changed, but the urinary sodium excretion and
urinary 20-HETE excretion were promoted by high salt intake in TG mice.
NKCC2 protein was reduced by high salt intake, but its mRNA was not. These
data suggest that 20-HETE of CYP4F2 TG mice exert natriuresis in renal
adaptation to elevated Naþ intake, in which reduction of renal NKCC2 protein
was involved through high salt-induced posttranscriptional regulation.
http://dx.doi.org/10.1016/j.krcp.2012.04.607284
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Background: Alterations in innate immunity play a role in renal damage in
experimental models but the role of these alterations in the progression of CKD
in humans is still poorly deﬁned. Procalcitonin (PCT), is a biomarker of innate
immunity produced by C-cells of the thyroid and by the adipose tissue.
Objectives: We measured serum plasma PCT levels in a cohort of 670
patients with stage 3–5 CKD and tested the relationship between this
biomarker metrics of adiposity, proteinuria, GFR and progression to kidney
failure over a 3 year follow-up. None of the patients had intercurrent
infectious or acute inﬂammatory processes.
Methods: PCT was measured by an ultrasensitive immunoluminometric
assay. The GFR was estimated by a Cystatin-C based equation. The
relationship between PCT and renal events was tested by multivariate
Cox’s regression and interaction analysis.
Results: Procalcitonin exceeded the upper limit of the normal range
(40.064 ng/mL) in 492 patients (67 %) while the corresponding ﬁgure
for high sensitivity CRP (41 mg/L) was 170 (%). PCT was higher (Po0.001)
in males and strongly associated with the GFR (r¼) as well as diabetes
(P¼0.004) and a history of cardiovascular (CV) events (P¼0.007).
Furthermore PCT was inversely related with Hb (r¼0.16, Po0.001) and
with serum albumin (r¼0.10, P¼0.009) and directly associated with CRP
(r¼0.23, Po0.001) and with white blood cells count (r¼0.12, P¼0.002). Of
note, PCT was higher (Po0.001) in patients with large waist hip ratio (IVth
quartile) than in those normal or high normal WHR (1st to 3rd quartiles).
During the follow up, PCT predicted the combined renal end-point (30%
GFR loss, dialysis or transplantation) (HR for 1 ng/ml increase: 2.37,
95%CI:1.25–4.48, P¼0.009) in a model adjusting for age, sex, diabetes, BP,
smoking, cholesterol, background cardiovascular events and PCT interacted
with baseline GFR in predicting renal outcomes. Indeed the risk of for the
combined end-point was minimal in patients with low PCT and high GFR
and maximal in those with low GFR and high PCT.
Conclusions: Plasma procalcitonin is a more sensitive biomarker of innate
immunity than CRP in CKD patients and in part reﬂects excessive adiposity.
High PCT in CKD patients predicts progression toward kidney failure. These
results are compatible with the hypothesis that alterations in innate
immunity play a role in the progression of CKD in humans.
http://dx.doi.org/10.1016/j.krcp.2012.04.608285
EFFECTS OF OMEGA-3 AND PROTEIN SUPPLEMENTATION ON
NUTRITIONAL AND INFLAMMATORY INDICES IN HEMODIALYSIS
PATIENTS – A PILOT STUDY.
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Intervention to correct malnutrition and chronic inﬂammation in dialysis
patients is often impeded by poor compliance due to medical and
